Abstract:BackgroundIdentification of genes that are specifically activated in restenosis lesions after percutaneous transluminal angioplasty represents a necessary step toward molecular manipulation designed to inhibit cellular proliferation responsible for such lesions. Whereas quiescent smooth muscle cells (contractile phenotype) preferentially express smooth muscle myosin, proliferating smooth muscle cells (synthetic phenotype) have been shown to preferentially express nonmuscle myosin in vitro. Accordingly, we analyzed the expression of a recently cloned isoform of human nonmuscle myosin heavy chain (MHC-B) in fresh human restenotic lesions. Methods and ResultsA total of 10 lesions, including four restenosis (three superficial femoral arterial lesions and one saphenous vein bypass lesion) and six primary (four superficial femoral arterial lesions and two coronary arterial lesions) obtained percutaneously by directional atherectomy, were processed for examination by in situ hybridization. In total, 150 tissue sections of restenotic lesions (66 sections), primary lesions (78 sections), and normal internal mammary artery (six sections) were hybridized with the nonmuscle MHC-B probe. Restenotic lesions showed intense hybridization to the nonmuscle MHC-B cRNA probe, as demonstrated by a clustering of more than 20 grains per cell nucleus in 80% of the cells examined within a high-power field (×250); in contrast, an equivalent degree of hybridization was observed in only 7% of cells within primary lesions (p<0.001). Results of immunocytochemistry using monoclonal antibody to smooth muscle actin indicated that cells demonstrating strong hybridization were smooth muscle in origin. ConclusionsThese findings demonstrate that 1) human vascular tissue obtained by percutaneous directional atherectomy constitutes appropriate biopsy material for gene expression studies at the mRNA level, and 2) nonmuscle MHC-B mRNA is present in greater abundance among restenotic versus primary vascular stenoses. These observations thus provide a rational basis to explore restenotic lesions on a larger scale to identify genes that are activated in these lesions and establish potential targets for future gene therapy.

Mesenteric lipoblastoma and cervical lipoblastomatosis: ultrasound, elastosonography, and computed tomography findings in two children

Infantile Abdominal and Pelvic Lipoblastomas: A Case Series

Case report: mesenteric lipoblastoma

Mesenteric lipoblastomatosis: an uncommon fat-containing childhood tumour diagnosed on imaging

A Rare Case of Giant Mesenteric Lipoblastoma in a 6-Year-Old Child and Review of the Literature

Lipoblastoma in children: Review of 12 cases

Imaging of head and neck lipoblastoma: case report and systematic review

Lipoblastoma: Diagnosis and surgical considerations

[Imaging characteristics of childhood lipoblastoma]

Lipoblastoma in infants and children

Nonmyxoid mediastinal lipoblastoma in a 2-year-old girl: Case report with US, CT, and MRI findings

Pelvic Lipoblastoma with Extension into Ischiorectal Fossa and Abdominal Lipoblastoma - Complete Excision by Laparoscopy in Children - A Report of Two Cases

Lipoblastoma: computed tomographic and magnetic resonance imaging features correlate with tumor behavior and pathology

A giant mesenteric lipoblastoma in an 18-month old infant: a case report and review of the literature

Lipoblastoma in childhood: About 10 cases

Lipoblastoma in infancy and childhood

Lipoblastoma presenting as a mesenteric mass in an infant

Evidence Implicating Nonmuscle Myosin in Restenosis: Use of In Situ Hybridization to Analyze Human Vascular Lesions Obtained by Directional Atherectomy

Cervicothoracic lipoblastoma: three case reports and review of literature

Mesenteric lipoblastoma: case report

Lipoblastoma: An important differential diagnosis of tumours of the hand in children